JP2014530744A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014530744A5 JP2014530744A5 JP2014538902A JP2014538902A JP2014530744A5 JP 2014530744 A5 JP2014530744 A5 JP 2014530744A5 JP 2014538902 A JP2014538902 A JP 2014538902A JP 2014538902 A JP2014538902 A JP 2014538902A JP 2014530744 A5 JP2014530744 A5 JP 2014530744A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- particles
- bioactive glass
- der
- carrier
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002245 particle Substances 0.000 claims description 36
- 239000005313 bioactive glass Substances 0.000 claims description 18
- 239000000463 material Substances 0.000 claims description 6
- 210000000988 bone and bone Anatomy 0.000 claims description 5
- 230000035876 healing Effects 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims 37
- 230000002745 absorbent Effects 0.000 claims 6
- 239000002250 absorbent Substances 0.000 claims 6
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 claims 6
- 230000002902 bimodal effect Effects 0.000 claims 5
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims 4
- 239000004568 cement Substances 0.000 claims 4
- 239000011248 coating agent Substances 0.000 claims 4
- 238000000576 coating method Methods 0.000 claims 4
- 229920002674 hyaluronan Polymers 0.000 claims 4
- 229960003160 hyaluronic acid Drugs 0.000 claims 4
- 150000001875 compounds Chemical class 0.000 claims 3
- 239000011521 glass Substances 0.000 claims 3
- 239000000017 hydrogel Substances 0.000 claims 3
- 229910052588 hydroxylapatite Inorganic materials 0.000 claims 3
- 239000007788 liquid Substances 0.000 claims 3
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 claims 3
- 150000003904 phospholipids Chemical class 0.000 claims 3
- 239000007787 solid Substances 0.000 claims 3
- 229920001661 Chitosan Polymers 0.000 claims 2
- 102000008186 Collagen Human genes 0.000 claims 2
- 108010035532 Collagen Proteins 0.000 claims 2
- 108010010803 Gelatin Proteins 0.000 claims 2
- 229920000615 alginic acid Polymers 0.000 claims 2
- 235000010443 alginic acid Nutrition 0.000 claims 2
- 229920001436 collagen Polymers 0.000 claims 2
- 229920000159 gelatin Polymers 0.000 claims 2
- 239000008273 gelatin Substances 0.000 claims 2
- 235000019322 gelatine Nutrition 0.000 claims 2
- 235000011852 gelatine desserts Nutrition 0.000 claims 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims 1
- 102000012422 Collagen Type I Human genes 0.000 claims 1
- 108010022452 Collagen Type I Proteins 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 claims 1
- 239000004721 Polyphenylene oxide Substances 0.000 claims 1
- 229940072056 alginate Drugs 0.000 claims 1
- 229960001126 alginic acid Drugs 0.000 claims 1
- 239000000783 alginic acid Substances 0.000 claims 1
- 150000004781 alginic acids Chemical class 0.000 claims 1
- 229910052586 apatite Inorganic materials 0.000 claims 1
- 229940045110 chitosan Drugs 0.000 claims 1
- 239000000499 gel Substances 0.000 claims 1
- 229940014259 gelatin Drugs 0.000 claims 1
- 239000003178 glass ionomer cement Substances 0.000 claims 1
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 claims 1
- 239000002985 plastic film Substances 0.000 claims 1
- 229920000570 polyether Polymers 0.000 claims 1
- 229920000642 polymer Polymers 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 238000005457 optimization Methods 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161550706P | 2011-10-24 | 2011-10-24 | |
| US61/550,706 | 2011-10-24 | ||
| PCT/US2012/061574 WO2013063033A1 (en) | 2011-10-24 | 2012-10-24 | Compositions and their use in bone healing |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017092997A Division JP6463880B2 (ja) | 2011-10-24 | 2017-05-09 | 組成物および骨の治癒におけるそれらの使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014530744A JP2014530744A (ja) | 2014-11-20 |
| JP2014530744A5 true JP2014530744A5 (https=) | 2015-11-05 |
| JP6169585B2 JP6169585B2 (ja) | 2017-07-26 |
Family
ID=47144146
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014538902A Active JP6169585B2 (ja) | 2011-10-24 | 2012-10-24 | 組成物および骨の治癒におけるそれらの使用 |
| JP2017092997A Active JP6463880B2 (ja) | 2011-10-24 | 2017-05-09 | 組成物および骨の治癒におけるそれらの使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017092997A Active JP6463880B2 (ja) | 2011-10-24 | 2017-05-09 | 組成物および骨の治癒におけるそれらの使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US8871235B2 (https=) |
| EP (1) | EP2771041B1 (https=) |
| JP (2) | JP6169585B2 (https=) |
| CN (1) | CN103957951B (https=) |
| AU (1) | AU2012329012B2 (https=) |
| BR (1) | BR112014009794B8 (https=) |
| CA (1) | CA2853457C (https=) |
| DK (1) | DK2771041T3 (https=) |
| ES (1) | ES2825423T3 (https=) |
| PL (1) | PL2771041T3 (https=) |
| PT (1) | PT2771041T (https=) |
| RU (2) | RU2665361C2 (https=) |
| WO (1) | WO2013063033A1 (https=) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7567129B2 (en) * | 2007-06-29 | 2009-07-28 | Intel Corporation | Monolithic flexible power amplifier using integrated tunable matching networks |
| US11225430B2 (en) * | 2012-03-26 | 2022-01-18 | Steven Jung | Bioactive glass scaffolds, and method of making |
| US9045362B2 (en) * | 2013-03-15 | 2015-06-02 | Mosci Corp. | Bioactive glass scaffolds, and method of making |
| US10207027B2 (en) | 2012-06-11 | 2019-02-19 | Globus Medical, Inc. | Bioactive bone graft substitutes |
| US8883195B2 (en) | 2013-03-14 | 2014-11-11 | Prosidyan, Inc. | Bioactive porous bone graft implants |
| US9381274B2 (en) | 2013-03-14 | 2016-07-05 | Prosidyan, Inc. | Bone graft implants containing allograft |
| US8889178B2 (en) | 2013-03-14 | 2014-11-18 | Prosidyan, Inc | Bioactive porous bone graft compositions in synthetic containment |
| US9775853B2 (en) * | 2013-03-15 | 2017-10-03 | Biomet Manufacturing, Llc. | Hemostatic compositions and methods |
| US9486483B2 (en) | 2013-10-18 | 2016-11-08 | Globus Medical, Inc. | Bone grafts including osteogenic stem cells, and methods relating to the same |
| US9539286B2 (en) | 2013-10-18 | 2017-01-10 | Globus Medical, Inc. | Bone grafts including osteogenic stem cells, and methods relating to the same |
| TWI651103B (zh) | 2013-12-13 | 2019-02-21 | 萊特醫技股份有限公司 | 多相骨移植替代材料 |
| US9579421B2 (en) | 2014-02-07 | 2017-02-28 | Globus Medical Inc. | Bone grafts and methods of making and using bone grafts |
| US9463264B2 (en) | 2014-02-11 | 2016-10-11 | Globus Medical, Inc. | Bone grafts and methods of making and using bone grafts |
| WO2016060947A1 (en) * | 2014-10-13 | 2016-04-21 | Novabone Products, Llc | Irrigation resistant compositions for regeneration of hard tissues and methods and kits of using the same |
| US10238507B2 (en) | 2015-01-12 | 2019-03-26 | Surgentec, Llc | Bone graft delivery system and method for using same |
| US10016529B2 (en) | 2015-06-10 | 2018-07-10 | Globus Medical, Inc. | Biomaterial compositions, implants, and methods of making the same |
| US11426489B2 (en) | 2015-06-10 | 2022-08-30 | Globus Medical, Inc. | Biomaterial compositions, implants, and methods of making the same |
| KR20190073349A (ko) * | 2016-10-05 | 2019-06-26 | 본어라이브 바이오메터리얼스 오와이 | 골 이식재 |
| DE102017220710A1 (de) * | 2017-11-20 | 2019-05-23 | Aesculap Ag | Implantat und Kit zum Behandeln und/oder biologischen Rekonstruieren eines Knochendefekts |
| US11116647B2 (en) | 2018-04-13 | 2021-09-14 | Surgentec, Llc | Bone graft delivery system and method for using same |
| US10687828B2 (en) | 2018-04-13 | 2020-06-23 | Surgentec, Llc | Bone graft delivery system and method for using same |
| CN108721702B (zh) * | 2018-06-29 | 2021-06-29 | 江西理工大学 | 一种镁/左旋聚乳酸复合骨支架的制备方法 |
| US11090412B2 (en) * | 2018-12-21 | 2021-08-17 | Zavation Medical Products Llc | Bone repair composition and kit |
| IT201900003947A1 (it) * | 2019-03-19 | 2020-09-19 | Mt Ortho S R L | Granulo in materiale metallico biocompatibile per vertebroplastica. |
| US11191868B2 (en) * | 2019-07-10 | 2021-12-07 | Synergy Biomedical, Llc | Implantable bodies comprising a regional composite |
| US11896736B2 (en) | 2020-07-13 | 2024-02-13 | Globus Medical, Inc | Biomaterial implants and methods of making the same |
| WO2024049993A2 (en) * | 2022-08-31 | 2024-03-07 | Biogennix, Llc | Tissue regeneration particles with a controlled structure |
| CN115554468B (zh) * | 2022-09-20 | 2023-12-01 | 中科硅骨(东莞)医疗器械有限公司 | 含生物活性玻璃的骨水泥及其制备方法和应用 |
| FR3160884A1 (fr) | 2024-04-06 | 2025-10-10 | Noraker | Pâte injectable à base de verre bioactif |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4775646A (en) | 1984-04-27 | 1988-10-04 | University Of Florida | Fluoride-containing Bioglass™ compositions |
| US4851046A (en) | 1985-06-19 | 1989-07-25 | University Of Florida | Periodontal osseous defect repair |
| FR2646084B1 (fr) | 1989-04-20 | 1994-09-16 | Fbfc International Sa | Materiau bioreactif de remplissage de cavites osseuses |
| US5658332A (en) | 1994-06-30 | 1997-08-19 | Orthovita, Inc. | Bioactive granules for bone tissue formation |
| FI101129B (sv) | 1995-01-13 | 1998-04-30 | Vivoxid Oy | Nya bioaktiva glas och deras användning |
| US6190684B1 (en) * | 1996-05-30 | 2001-02-20 | University Of Florida Research Foundation, Inc. | Injectable bio-active glass in a dextran suspension |
| FI103715B (fi) | 1997-04-21 | 1999-08-31 | Vivoxid Oy | Uusi komposiitti ja sen käyttö |
| US6228386B1 (en) | 1999-04-23 | 2001-05-08 | Unicare Biomedical, Inc. | Compositions and methods to repair osseous defects |
| ATE295829T1 (de) | 2001-03-30 | 2005-06-15 | King S College London | Verwendung von biologisch aktivem glas zum schneiden von biologisch aktivem glas |
| US7767221B2 (en) | 2004-03-05 | 2010-08-03 | The Trustees Of Columbia University In The City Of New York | Multi-phased, biodegradable and osteointegrative composite scaffold for biological fixation of musculoskeletal soft tissue to bone |
| US20050287180A1 (en) * | 2004-06-15 | 2005-12-29 | Chen Andrew X | Phospholipid compositions and methods for their preparation and use |
| GB0516157D0 (en) * | 2005-08-05 | 2005-09-14 | Imp College Innovations Ltd | Process for preparing bioglass scaffolds |
| US8288344B2 (en) * | 2007-03-15 | 2012-10-16 | Musculoskeletal Transplant Foundation | Ceramic composition for filling bone defects |
| WO2009144455A2 (en) * | 2008-05-27 | 2009-12-03 | Imperial Innovations Limited | Process for producing porous scaffolds from sinterable glass |
| US8647614B2 (en) | 2009-02-18 | 2014-02-11 | Orthovita, Inc. | Method for stabilizing vertebral body architecture |
| KR20120101021A (ko) * | 2009-10-29 | 2012-09-12 | 프로시다이안 인코포레이티드 | 골 이식재 |
| EP2322134B1 (en) * | 2009-11-12 | 2012-09-12 | BonAlive Biomaterials Oy | Implantable paste and its use |
| US8778378B2 (en) | 2009-12-21 | 2014-07-15 | Orthovita, Inc. | Bioactive antibacterial bone graft materials |
| EP2558034A2 (en) * | 2010-01-12 | 2013-02-20 | Medtronic, Inc. | Particle/polyurethane composites and methods thereof |
| US20110243913A1 (en) | 2010-04-06 | 2011-10-06 | Orthovita, Inc. | Biomaterial Compositions and Methods of Use |
-
2012
- 2012-10-24 AU AU2012329012A patent/AU2012329012B2/en active Active
- 2012-10-24 CA CA2853457A patent/CA2853457C/en active Active
- 2012-10-24 JP JP2014538902A patent/JP6169585B2/ja active Active
- 2012-10-24 RU RU2014121023A patent/RU2665361C2/ru active
- 2012-10-24 PT PT127834729T patent/PT2771041T/pt unknown
- 2012-10-24 EP EP12783472.9A patent/EP2771041B1/en active Active
- 2012-10-24 PL PL12783472T patent/PL2771041T3/pl unknown
- 2012-10-24 WO PCT/US2012/061574 patent/WO2013063033A1/en not_active Ceased
- 2012-10-24 CN CN201280058570.5A patent/CN103957951B/zh active Active
- 2012-10-24 ES ES12783472T patent/ES2825423T3/es active Active
- 2012-10-24 US US13/659,095 patent/US8871235B2/en active Active
- 2012-10-24 DK DK12783472.9T patent/DK2771041T3/da active
- 2012-10-24 BR BR112014009794A patent/BR112014009794B8/pt active IP Right Grant
- 2012-10-24 RU RU2018129876A patent/RU2018129876A/ru not_active Application Discontinuation
-
2013
- 2013-04-23 US US13/868,388 patent/US8506981B1/en active Active
-
2017
- 2017-05-09 JP JP2017092997A patent/JP6463880B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014530744A5 (https=) | ||
| Li et al. | Pore size of 3D-printed polycaprolactone/polyethylene glycol/hydroxyapatite scaffolds affects bone regeneration by modulating macrophage polarization and the foreign body response | |
| RU2018129876A (ru) | Композиции и их применение в регенерации костей | |
| Van Der Heide et al. | 3D printing of inorganic-biopolymer composites for bone regeneration | |
| Ding et al. | Chitosan/dextran hydrogel constructs containing strontium-doped hydroxyapatite with enhanced osteogenic potential in rat cranium | |
| Huang et al. | Black phosphorus hydrogel scaffolds enhance bone regeneration via a sustained supply of calcium-free phosphorus | |
| Srinivasan et al. | Biocompatible alginate/nano bioactive glass ceramic composite scaffolds for periodontal tissue regeneration | |
| Wang et al. | Bioadhesive microporous architectures by self-assembling polydopamine microcapsules for biomedical applications | |
| Li et al. | Multifunctional chitosan-45S5 bioactive glass-poly (3-hydroxybutyrate-co-3-hydroxyvalerate) microsphere composite membranes for guided tissue/bone regeneration | |
| Nair et al. | Graphene oxide nanoflakes incorporated gelatin–hydroxyapatite scaffolds enhance osteogenic differentiation of human mesenchymal stem cells | |
| Isikli et al. | Development of porous chitosan–gelatin/hydroxyapatite composite scaffolds for hard tissue‐engineering applications | |
| CN102973982B (zh) | 应用于软硬组织修复与再生的生物医学材料 | |
| Moses et al. | Mesoporous silk-bioactive glass nanocomposites as drug eluting multifunctional conformal coatings for improving osseointegration and bactericidal properties of metal implants | |
| Gaharwar et al. | Addition of chitosan to silicate cross-linked PEO for tuning osteoblast cell adhesion and mineralization | |
| Amirthalingam et al. | Injectable in situ shape-forming osteogenic nanocomposite hydrogel for regenerating irregular bone defects | |
| Raja et al. | Multifunctional calcium-deficient hydroxyl apatite–alginate core–shell-structured bone substitutes as cell and drug delivery vehicles for bone tissue regeneration | |
| Liu et al. | Magnesium ammonium phosphate composite cell-laden hydrogel promotes osteogenesis and angiogenesis in vitro | |
| Zhang et al. | Calcium‐capturing hydrogel with self‐reinforced multi‐dynamic networks for effective periodontal bone regeneration in three‐dimension | |
| Kadi et al. | Fabrication and characterization of 3D-printed composite scaffolds of coral-derived hydroxyapatite nanoparticles/polycaprolactone/gelatin carrying doxorubicin for bone tissue engineering | |
| Sui et al. | Evolution of a mesoporous bioactive glass scaffold implanted in rat femur evaluated by 45Ca labeling, tracing, and histological analysis | |
| Rajabi et al. | Development and optimisation of hydroxyapatite-polyethylene glycol diacrylate hydrogel inks for 3D printing of bone tissue engineered scaffolds | |
| Maureira et al. | Preparation and osteogenic properties of nanocomposite hydrogel beads loaded with nanometric bioactive glass particles | |
| Hassan et al. | Correlation between Ca release and osteoconduction by 3D-printed hydroxyapatite-based templates | |
| Zhou et al. | Influence of Nano-Bioactive Glass (NBG) content on properties of gelatin-hyaluronic acid/NBG composite scaffolds | |
| Xu et al. | Optimized bone regeneration in calvarial bone defect based on biodegradation-tailoring dual-shell biphasic bioactive ceramic microspheres |